SCHEMBL7143500

SCHEMBL7143500

O=c1[nH]c2ccccc2n1CCBr

nearest known ligand 0.66

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.64
HPGD P15428 2/20 0.64
HTT P42858 2/20 0.64
ALDH1A1 P00352 1/20 0.64
MAPT P10636 1/20 0.64
TSHR P16473 1/20 0.64
MAPK1 P28482 1/20 0.64
SMN1; SMN2 Q16637 1/20 0.64
TDP1 Q9NUW8 1/20 0.64
MEN1 O00255 1/20 0.64
CYP1A2 P05177 1/20 0.64
KMT2A Q03164 1/20 0.64
POLB P06746 1/20 0.59
RAB9A P51151 1/20 0.58
HTR7 P34969 5/20 0.55
P2RX7 Q99572 2/20 0.51
DAO P14920 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30546561 1.00 LMNA (0.64) LMNAHPGDHTTALDH1A1MAPT
SCHEMBL6397082 0.90 LMNA (0.69) LMNAHPGDHTTALDH1A1MAPT
SCHEMBL30704400 0.88 LMNA (0.68) LMNAHPGDHTTALDH1A1MAPT
SCHEMBL11037269 0.87 LMNA (0.66) LMNAHPGDHTTALDH1A1MAPT
SCHEMBL11039673 0.87 LMNA (0.66) LMNAHPGDHTTALDH1A1MAPT
SCHEMBL30947438 0.85 LMNA (0.78) LMNAHPGDHTTALDH1A1MAPT
SCHEMBL27031062 0.84 POLB (0.58) LMNAHPGDHTTALDH1A1MAPT
SCHEMBL763166 0.82 LMNA (0.64) LMNAHPGDHTTALDH1A1MAPT
SCHEMBL2149052 0.82 LMNA (0.64) LMNAHPGDHTTALDH1A1MAPT
SCHEMBL961132 0.82 LMNA (0.64) LMNAHPGDHTTALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116514824-A Tri-ring compound, preparation method and application thereof 上海科技大学 2023-08-01 CN disclosed
EP-0808313-B1 ANTIPSYCHOTIC 4-(1H-INDOLYL-1-YL)-1-SUBSTITUTED PIPERIDINE DERIVATIVES JANSSEN PHARMACEUTICA NV (BE) 2003-08-13 EP disclosed
US-5919788-A PSYCHOLOGICAL DISORDERS JANSSEN PHARMACEUTICA, N.V. (BE) 1999-07-06 US disclosed
EP-0822814-A4 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS MERCK & CO INC (US) 1998-12-09 EP disclosed
EP-0822814-A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS Merck & Co., Inc. (US) 1998-02-11 EP disclosed
US-5668148-A BENIGN PROSTATIC HYPERTROPHY MERCK & CO., INC. (US) 1997-09-16 US disclosed
WO-1996032938-A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS MERCK & CO., INC. (US) 1996-10-24 WO disclosed
EP-0282133-B1 1-ALKYL SUBSTITUTED BENZIMIDAZOLE DERIVATIVES JANSSEN PHARMACEUTICA N.V. (BE) 1993-07-28 EP disclosed
US-5075301-A FURAN DERIVATIVES USEFUL FOR THE TREATMENT OF GASTRO-INTESTINAL DISORDERS KYOWA HAKKO KOGYO, CO., LTD. (JP) 1991-12-24 US disclosed
EP-0413343-A2 Furan derivatives KYOWA HAKKO KOGYO CO., LTD. (JP) 1991-02-20 EP disclosed
US-4943580-A ANTIALLERGENS JANSSEN PHARMACEUTICA N.V. (BE) 1990-07-24 US disclosed
US-4680296-A ANTIALLERGENS, ANTIPRUITIC AGENTS SYNTHELABO (FR) 1987-07-14 US disclosed